Private Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17M Buy
604,878
+28,031
+5% +$746K 1.31% 23
2025
Q4
$14.4M Buy
576,847
+33,635
+6% +$848K 1.02% 26
2025
Q3
$13.8M Buy
543,212
+27,866
+5% +$688K 0.99% 27
2025
Q2
$12.5M Sell
515,346
-77,813
-13% -$1.81M 0.97% 26
2025
Q1
$15M Buy
593,159
+13,310
+2% +$348K 1.24% 24
2024
Q4
$15.4M Buy
579,849
+132,312
+30% +$3.59M 1.18% 25
2024
Q3
$13M Buy
447,537
+31,321
+8% +$914K 1.03% 28
2024
Q2
$11.6M Sell
416,216
-8,533
-2% -$235K 0.86% 28
2024
Q1
$11.8M Sell
424,749
-609
-0.1% -$16.9K 0.94% 28
2023
Q4
$12.2M Sell
425,358
-43,646
-9% -$1.32M 1.04% 26
2023
Q3
$15.6M Sell
469,004
-12,003
-2% -$424K 1.49% 20
2023
Q2
$17.6M Buy
481,007
+64,836
+16% +$2.52M 1.62% 20
2023
Q1
$17M Buy
416,171
+47,048
+13% +$2.03M 1.7% 20
2022
Q4
$18.9M Buy
369,123
+928
+0.3% +$44.5K 2.16% 17
2022
Q3
$16.1M Sell
368,195
-2,373
-0.6% -$115K 2.06% 18
2022
Q2
$19.4M Sell
370,568
-4,911
-1% -$250K 2.26% 16
2022
Q1
$19.4M Buy
375,479
+27
+0% +$1.4K 1.74% 20
2021
Q4
$22.2M Sell
375,452
-12,521
-3% -$620K 1.87% 17
2021
Q3
$16.7M Sell
387,973
-1,982
-0.5% -$87.8K 1.55% 20
2021
Q2
$15.3M Buy
389,955
+51,401
+15% +$2M 1.41% 24
2021
Q1
$12.3M Buy
338,554
+50,224
+17% +$1.78M 1.3% 30
2020
Q4
$10.6M Sell
288,330
-12,930
-4% -$474K 1.15% 28
2020
Q3
$10.5M Buy
301,260
+18,317
+6% +$642K 1.23% 24
2020
Q2
$8.78M Buy
282,943
+20,328
+8% +$691K 1.2% 26
2020
Q1
$8.13M Sell
262,615
-5,341
-2% -$182K 1.37% 22
2019
Q4
$9.96M Sell
267,956
-16,828
-6% -$599K 1.36% 23
2019
Q3
$9.71M Sell
284,784
-189,170
-40% -$6.88M 1.51% 21
2019
Q2
$19.5M Sell
473,954
-671
-0.1% -$26.6K 3% 10
2019
Q1
$19.1M Sell
474,625
-13,488
-3% -$540K 3.15% 9
2018
Q4
$20.2M Sell
488,113
-741
-0.2% -$30.8K 3.91% 8
2018
Q3
$20.4M Buy
488,854
+446
+0.1% +$17.2K 3.12% 8
2018
Q2
$16.8M Buy
488,408
+355
+0.1% +$12.1K 2.83% 9
2018
Q1
$16.4M Buy
488,053
+19,128
+4% +$658K 2.86% 10
2017
Q4
$16.1M Buy
468,925
+3,896
+0.8% +$133K 2.98% 8
2017
Q3
$15.8M Buy
465,029
+8,710
+2% +$280K 3.17% 9
2017
Q2
$14.5M Sell
456,319
-55,208
-11% -$1.74M 3.16% 10
2017
Q1
$16.6M Sell
511,527
-15,299
-3% -$482K 3.68% 5
2016
Q4
$16.2M Sell
526,826
-2,930
-0.6% -$89.4K 3.86% 6
2016
Q3
$17M Sell
529,756
-9,929
-2% -$332K 4.09% 4
2016
Q2
$18M Sell
539,685
-5,022
-0.9% -$160K 4.33% 5
2016
Q1
$15.3M Buy
544,707
+25,201
+5% +$720K 3.68% 5
2015
Q4
$15.9M Buy
519,506
+5,049
+1% +$159K 3.72% 5
2015
Q3
$15.3M Buy
514,457
+8,158
+2% +$262K 3.86% 4
2015
Q2
$16.1M Buy
506,299
+35,993
+8% +$1.17M 3.64% 4
2015
Q1
$15.5M Buy
470,306
+60,042
+15% +$1.91M 3.57% 4
2014
Q4
$12.1M Sell
410,264
-8,590
-2% -$246K 2.85% 6
2014
Q3
$11.8M Sell
418,854
-15,178
-3% -$426K 2.58% 7
2014
Q2
$12.2M Sell
434,032
-16,284
-4% -$464K 2.69% 7
2014
Q1
$13.7M Buy
450,316
+15,620
+4% +$466K 3.24% 4
2013
Q4
$12.6M Sell
434,696
-24,313
-5% -$708K 2.82% 5
2013
Q3
$12.5M Sell
459,009
-4,057
-0.9% -$110K 2.96% 5
2013
Q2
$12.3M Buy
+463,066
New +$12.8M 3.07% 4

Other funds holding PFE

Private Wealth Partners's PFE Position: Q1 2026 in Review

Private Wealth Partners increased its Pfizer (PFE) stake by 4.9% in Q1 2026, buying an estimated $746K and bringing the position to 604,878 shares worth $17M. The position accounts for 1.31% of the portfolio, ranked #23.

Private Wealth Partners first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.2M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Private Wealth Partners held 604,878 shares of Pfizer worth $17M as of Q1 2026.
  • Private Wealth Partners bought 28,031 Pfizer shares in Q1 2026, an estimated $746K.
  • Pfizer made up 1.31% of Private Wealth Partners's portfolio in Q1 2026, its #23 holding.
  • Private Wealth Partners first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Private Wealth Partners's Pfizer position peaked at $22.2M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Private Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.